Although the literature findings regarding the expression of IL-6 and TNF-α are still controversial, restrictive, and inconsistent, the status of IL-6 as a major mediator for modulating CRP synthesis and its increased levels in patients with PCOS suggest the occurrence of interactions involving IL-6 and TNF-α. Here, IL6 is linked to polycystic ovary syndrome.